Home›Deuruxolitinib Phosphate›Deuruxolitinib Phosphate + Mao Inhibitors

Does Deuruxolitinib Phosphate Interact with Mao Inhibitors?

Deuruxolitinib Phosphate and Mao Inhibitors have a contraindicated drug interaction according to U.S. FDA drug labeling data. LEQSELVI is contraindicated in patients taking moderate or strong CYP2C9 inhibitors. Concomitant use increases deuruxolitinib exposure and may increase risk of serious adverse reactions such as thrombosis. The mechanism involves cyp2c9 inhibition increases deuruxolitinib exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Deuruxolitinib Phosphate and Mao Inhibitors occurs because cyp2c9 inhibition increases deuruxolitinib exposure. Clinically, this means leqselvi is contraindicated in patients taking moderate or strong cyp2c9 inhibitors. concomitant use increases deuruxolitinib exposure and may increase risk of serious adverse reactions such as thrombosis. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Deuruxolitinib Phosphate and your doctor is considering prescribing Mao Inhibitors (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Deuruxolitinib Phosphate(Leqselvi)+💊 Mao Inhibitors

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
NLP:deuruxolitinib phosphate

What this means in plain English

LEQSELVI is contraindicated in patients taking moderate or strong CYP2C9 inhibitors. Concomitant use increases deuruxolitinib exposure and may increase risk of serious adverse reactions such as thrombosis.

What the FDA label says

"CYP2C9 inhibition increases deuruxolitinib exposure"

📖 Source: NLP:deuruxolitinib phosphate

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Deuruxolitinib Phosphate and Mao Inhibitors against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.